Piet Wigerinck

Piet Wigerinck

Director/Board Member at IPSEN

Net worth: 124 266 $ as of 2026-05-30

60 year
Health Technology
Commercial Services
Health Services

Profile

Currently, Piet Wigerinck is Chief Scientific Officer of Galapagos NV. He is also on the board of Ipsen SA and Ipsen Pharma SAS. In the past he was Vice President-Drug Discovery & Early Development at Tibotec Pharmaceuticals and Vice President of Drug Discovery & Development Solutions Ltd. Dr. Wigerinck received a doctorate from Katholieke Universiteit Leuven.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2025-12-30 680 ( 0% ) 124 266 $ 2026-05-30

Piet Wigerinck active positions

CompaniesPositionStart
IPSEN Director/Board Member 2018-04-30
Director/Board Member -
Director/Board Member -
Director/Board Member -
Director/Board Member -

Former positions of Piet Wigerinck

CompaniesPositionEnd
LAKEFRONT BIOTHERAPEUTICS NV Chief Tech/Sci/R&D Officer 2021-12-30
UZA Foundation
Director/Board Member -
Founder -
Corporate Officer/Principal -
░░░░ ░░░░░░░░░ ░░░░░ ░░░░░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
See the detail of Piet Wigerinck's experience

Training of Piet Wigerinck

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

61

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Health Technology

Health Technology

Health Services

Health Technology

Consumer Services

Commercial Services

Commercial Services

Health Technology

Health Technology

Health Technology

UZA Foundation

  1. Stock Market
  2. Insiders
  3. Piet Wigerinck
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!